Abstract
Gastric carcinogenesis is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. We analysed the patterns of chromosomal instability in 35 gastric carcinomas and their clinical correlations. With microarray competitive genomic hybridization, genomewide chromosomal copy number changes can be studied with high resolution and sensitivity. A genomewide scanning array with 2275 BAC and P1 clones spotted in triplicate was used. This array provided an average resolution of 1.4 Mb across the genome. Patterns of chromosomal aberrations were analysed by hierarchical cluster analysis of the normalized log2 tumour to normal fluorescence ratios of all clones, and cluster membership was correlated to clinicopathological data including survival. Hierarchical cluster analysis revealed three groups with different genomic profiles that correlated significantly with lymph node status (P=0.02). Moreover, gastric cancer cases from cluster 3 showed a significantly better prognosis than those from clusters 1 and 2 (P=0.02). Genomic profiling of gastric adenocarcinomas based on microarray analysis of chromosomal copy number changes predicted lymph node status and survival. The possibility to discriminate between patients with a high risk of lymph node metastasis could clinically be helpful for selecting patients for extended lymph node resection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CGH:
-
comparative genomic hybridisation
- H&E:
-
haematoxylin & eosin
References
Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW and Pinkol D . (2000). Nat. Genet., 25, 144–146.
Alizadeh AA, Ross DT, Perou CM and van de Rijn M . (2001). J. Pathol., 195, 41–52.
Bonenkamp JJ, Hermans J, Sasako M and van de Velde CJ . (1999). N. Engl. J. Med., 340, 908–914.
Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J and Joypaul V et al. (1999). Br. J. Cancer., 79, 1522–1530.
Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. 95, 14863–14868.
Ekstrom AM, Held M, Hansson LE, Engstrand L and Nyren O . (2001). Gastroenterology, 121, 784–791.
Grieken van NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, Craanen ME, Bloemena E, Meuwissen SG, Baak JP and Kuipers EJ . (2000). J. Pathol., 192, 301–306.
Guan X, Fu S, Xia J, Fang Y, Sham JS, Du BD, Zhou H, Lu S, Wang BQ, Lin YZ, Liang Q, Li XM, Du B, Ning XM, Du JR, Li P and Trent JM . (2000). Cancer Genet. Cytogenet., 123, 27–34.
Hausen zur A, van Grieken NC, Meijer GA, Hermsen MA, Bloemena E, Meuwissen SG, Baak JP, Kuipers EJ and Van den Brule AJ . (2001). Gastroenterology, 121, 612–618.
Hermsen MA, Baak JP, Meijer GA, Weiss JM, Walboomers JW, Snijders PJ and Van Diest PJ . (1998). J. Pathol., 186, 356–362.
Hermsen M, Postma C, Baak J, Weiss MM, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A and Meijer G . (2002). Gastroenterology, 123, 1109–1119.
Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG and Pinkel D . (2002). Genome Res., 12, 325–332.
Koizumi Y, Tanaka S and Mou R . (1997). Clin. Cancer Res., 3, 1067–1076.
Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M and Nordling S, Haapiainen R, Kivilaakso E and Knuutila S . (1997). Genes Chromosomes Cancer, 20, 38–43.
Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapiainen R, Kivilaakso E and Knuutila S . (1998). Cancer Genet. Cytogenet., 107, 32–36.
Koo SH, Kwon KC, Shin SY, Jeon YM, Park JW, Kim S and Noh SM . (2000). Cancer Genet. Cytogenet., 117, 97–103.
Lauren P . (1965). Acta Pathol. Microbiol. Scand., 64, 31–49.
Parkin DM . (2001). Lancet Oncol., 2, 533–543.
Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW and Albertson DG . (1998). Nat. Genet., 20, 207–211.
Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Pogglo T, Gerald W, Loda M, Lander ES and Golub TR . (2001). Proc. Natl. Acad. Sci. USA, 98, 15149–15154.
Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T and Inazawara J . (1999). Genes Chromosomes Cancer, 24, 299–305.
Sasako M, McCulloch P, Kinoshita T and Maruyama K . (1995). Br. J. Surg., 82, 346–351.
Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR and Sellers WR . (2002). Cancer Cell, 1, 203–209.
Sipponen P, Hyvarinen H, Seppala K and Blaser MJ . (1998). Aliment. Pharmacol. Therap., 12 (Suppl 1), 61–71.
Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D and Albertson DG . (2001). Nat. Genet., 29, 263–264.
Sudbery P . (2002). Human Molecular Genetics, 2nd edn. Pearson Education Limited: Harlow.
van Dekken H, Alers JC, Riegman PHJ, Rosenberg C, Tilanus HW and Vissers K . (2001). Am. J. Pathol., 158, 1961–1967.
Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H Jr, Powell SM, Knuutila S, Kallioniemi A and El-Rifai W . (2002). Cancer Res., 62, 2625–2629.
Veer 't LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.
Visser O, Coebergh J, Schouten L and Dijck Jv . (2001). Incidence of Cancer in The Netherlands 1997. Utrecht.
Weiss MM, Hermsen MA, Meijer GA, van Grieken NC, Baak JP, Kuipers EJ and Van Diest PJ . (1999). Mol. Pathol., 52, 243–251.
Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SG, Van Diest PJ, Albertson DG and Meijer GA . (2003). J. Pathol., in press.
Wu MS, Chang MC, Huang SP, Tseng CC, Sheu JC, Lin YW, Shun CT, Lin MT and Lin JT . (2001). Genes Chromosomes Cancer, 30, 80–86.
Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, Wang TH and Lin JT . (1997). Gastroenterology, 112, 1457–1465.
Acknowledgements
We thank Nils Brown for printing the microarray slides. This work was supported by the University Stimulation Foundation of the VU University (USF).
Author information
Authors and Affiliations
Corresponding author
Additional information
Grant support: University Stimulation Fund
Rights and permissions
About this article
Cite this article
Weiss, M., Kuipers, E., Postma, C. et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 22, 1872–1879 (2003). https://doi.org/10.1038/sj.onc.1206350
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206350
Keywords
This article is cited by
-
A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer
BMC Cancer (2021)
-
Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information
Scientific Reports (2016)
-
Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer
Gastric Cancer (2016)
-
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
Leukemia (2009)
-
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
Virchows Archiv (2009)